A hematopoietic stem cell transplant recipient is ordered irradiated platelets. The blood bank has amotosalen/UVA pathogen-reduced apheresis platelets in inventory. How may these platelets be used for this patient?
1They must also be washed before issue
2They must also be irradiated before issue
3They may be issued in place of irradiated platelets✓ 정답
4They cannot be given to transplant recipients
해설
Amotosalen/UVA treatment cross-links nucleic acids and inactivates donor T lymphocytes, so FDA-approved pathogen-reduced platelets may be used in place of gamma irradiation to prevent TA-GVHD. Additional irradiation or washing is not required for this purpose.